An Economic Model to Compare Linezolid, Vancomycin, and Teicoplanin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia In Brazil
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1373
https://www.valueinhealthjournal.com/article/S1098-3015(15)01430-8/fulltext
Title :
An Economic Model to Compare Linezolid, Vancomycin, and Teicoplanin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia In Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01430-8&doi=10.1016/j.jval.2015.03.1373
First page :
A236
Section Title :
Infection
Open access? :
No
Section Order :
839